Advertisement

Topics

for Cancer Genetics, Inc. Company Profile

10:26 EDT 21st June 2018 | BioPortfolio

Cancer Genetics, Inc. (CGI) is an emerging leader in the field of personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual patient. CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our reference laboratory is both CLIA certified and accredited by the College of American Pathologists. In addition, we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey. The company has been built on a foundation of world-class scientific knowledge and IP in solid and hematologic cancers, as well as strong research collaborations with major cancer centers such as Cleveland Clinic and the National Cancer Institute.


News Articles [3015 Associated News Articles listed on BioPortfolio]

Myriad Genetics shows strong commitment, support in the fight against colorectal cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment and genetic testing during Nat...

RM LAW Announces Class Action Lawsuit Against Cancer Genetics, Inc.

Cancer Genetics shareholders may, no later than June 4, 2018, move the Court for appointment as a lead plaintiff of the Class.  If you Read more...

#news #biotech Pieris, Seattle Genetics pen $1.2B biobucks pact for next-gen cancer drugs

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pieris, Seattle Genetics pen $1.2B biobucks pact for next-gen cancer drugs .B...

Seattle Genetics To Acquire Cascadian Therapeutics

NewsThe acquisition will enhance Seattle Genetics’ portfolio of solid tumor programs with potential rapid registration pathways and provides global rights to a pivotal Phase 2 program in development...

FDA clears Cancer Genetics' Tissue of Origin test

The FDA has granted Cancer Genetics 510(k) clearance for its Tissue of Origin gene expression test, which evaluates 2,000 ind -More- 

Unum gets $5mm investment from Seattle Genetics

Concurrent with closing its initial public offering, Unum Therapeutics Inc. sold partner Seattle Genetics Inc. 416,666 common shares at the IPO price of $12 each, for proceeds of $5mm. The companies t...

Seattle Genetics to Acquire Cascadian Therapeutics for $614 Million, Adding Late-Stage Breast Cancer Program

att BOTHELL, Wash. & SEATTLE–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Cascadian Therapeutics, Inc. (Nasdaq:CASC) today announced the signing of a definitive merger agr...

EDC4: New gene involved in familial breast cancer

(Universitat Autonoma de Barcelona) An international research consortium led by Dr Jordi Surrallés, director of the Genetics Service at the Hospital de Sant Pau and professor of Genetics at the UAB, ...

PubMed Articles [6511 Associated PubMed Articles listed on BioPortfolio]

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

Genetic Testing: How Genetics and Genomics Can Affect Healthcare Disparities
.

Advances in oncology care have transformed treatment approaches as genetics and genomics analyses promote implementation of personalized medicine. Genetics and genomics research in TP53 have demonstra...

Prevalence of hereditary cancer susceptibility syndromes in children with cancer in a highly consanguineous population.

Hereditary cancer susceptibility syndromes (HCSS) are reported in up to one-third of children with cancer. Diagnosis of HCSS is crucial for implementation of surveillance protocols. We identified chil...

Understanding the HPV integration and its progression to cervical cancer.

Cervical cancer is one of the main causes of female cancer death worldwide, and human papilloma virus (HPV) its causal agent. To investigate viral oncogenesis several studies have focused on the effec...

Genetic populations and virulence factors of Helicobacter pylori.

Helicobacter pylori is a bacterium that has infected more than half of the human population worldwide. This bacterium is closely associated with serious human diseases, such as gastric cancer, and ide...

Clinical Trials [8071 Associated Clinical Trials listed on BioPortfolio]

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

The goal of this research study is to test the effects of online genetic education alone or in combination with telephone genetic counseling in order to compare the two methods and the str...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [1449 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Genetics & IVF Institute

Genetics & IVF was the first U.S. center to introduce non-surgical ultrasound guided egg retrieval for IVF Genetics & IVF achieved America's first frozen embryo twin birth Genetics & IVF was the first...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE...

More Information about "for Cancer Genetics, Inc." on BioPortfolio

We have published hundreds of for Cancer Genetics, Inc. news stories on BioPortfolio along with dozens of for Cancer Genetics, Inc. Clinical Trials and PubMed Articles about for Cancer Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of for Cancer Genetics, Inc. Companies in our database. You can also find out about relevant for Cancer Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record